Intelligent Bio Solutions (NASDAQ:INBS) Trading Down 2.1% – Time to Sell?

Intelligent Bio Solutions Inc. (NASDAQ:INBS)’s share price dropped 2.1% during mid-day trading on Tuesday . The company traded as low as $1.39 and last traded at $1.43. Approximately 74,089 shares traded hands during mid-day trading, a decline of 15% from the average daily volume of 87,097 shares. The stock had previously closed at $1.46.

Intelligent Bio Solutions Stock Performance

The firm’s 50-day moving average is $1.51 and its 200 day moving average is $1.55.

Intelligent Bio Solutions (NASDAQ:INBS) last released its quarterly earnings data on Thursday, November 7th. The company reported ($0.70) EPS for the quarter, missing analysts’ consensus estimates of ($0.53) by ($0.17). The firm had revenue of $872.29 million for the quarter. Intelligent Bio Solutions had a negative return on equity of 147.50% and a negative net margin of 288.35%. Equities research analysts expect that Intelligent Bio Solutions Inc. will post -1.25 EPS for the current fiscal year.

Intelligent Bio Solutions Company Profile

Intelligent Bio Solutions Inc, a medical technology company, developing non-invasive, real-time monitoring, and diagnostic tests for patients and their primary health practitioners. It offers saliva glucose biosensor for diabetes management that measures glucose in saliva. The company also provides intelligent fingerprinting drug screening system, a revolutionizing portable testing through fingerprint sweat analysis, which has the potential for broader applications in additional fields; and biosensor platform for biochemistry, immunology, tumor markers, hormones, and nucleic acid diagnostic modalities.